AZ completes agreement for Rhinocort Aqua rights
05 December 2016 07:00 ASTRAZENECA COMPLETES AGREEMENT WITHCILAG GMBH INTERNATIONAL FOR RIGHTSTO RHINOCORT AQUA OUTSIDE THE US AstraZeneca today announced that it has completed the agreement with Cilag GmbH International, an affiliate of Johnson & Johnson, for the divestment of the rights to Rhinocort Aqua outside the US. Rhinocort Aqua is a nasal spray indicated for allergic and non-allergic